Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA] includes 3 drugs with a combined 1,156 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
1,156
Combined Reports
All Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| PEXIDARTINIB | Turalio | 970 | 17 | 91 | 1.8% |
| VIMSELTINIB | ROMVIMZA | 170 | 0 | 5 | N/A |
| AXATILIMAB | NIKTIMVO | 16 | 2 | 13 | 12.5% |
Common Side Effects in Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Fatigue | 435 | 3 |
| Product dose omission issue | 347 | 3 |
| Hair colour changes | 327 | 1 |
| Nausea | 233 | 2 |
| Pruritus | 209 | 0 |
| Rash | 146 | 2 |
| Aspartate aminotransferase increased | 140 | 3 |
| Off label use | 130 | 6 |
| Alanine aminotransferase increased | 124 | 1 |
| Headache | 120 | 0 |